These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 22864640)

  • 1. High frequency of BRCA1 founder mutations in Polish women with nonfamilial breast cancer.
    Gaj P; Kluska A; Nowakowska D; Bałabas A; Piątkowska M; Dabrowska M; Niwińska A; Ostrowski J
    Fam Cancer; 2012 Dec; 11(4):623-8. PubMed ID: 22864640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency and spectrum of founder and non-founder BRCA1 and BRCA2 mutations in a large series of Russian breast cancer and ovarian cancer patients.
    Sokolenko AP; Sokolova TN; Ni VI; Preobrazhenskaya EV; Iyevleva AG; Aleksakhina SN; Romanko AA; Bessonov AA; Gorodnova TV; Anisimova EI; Savonevich EL; Bizin IV; Stepanov IA; Krivorotko PV; Berlev IV; Belyaev AM; Togo AV; Imyanitov EN
    Breast Cancer Res Treat; 2020 Nov; 184(1):229-235. PubMed ID: 32776218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic testing in Poland and Ukraine: should comprehensive germline testing of
    Nguyen-Dumont T; Karpinski P; Sasiadek MM; Akopyan H; Steen JA; Theys D; Hammet F; Tsimiklis H; Park DJ; Pope BJ; Slezak R; Stembalska A; Pesz K; Kitsera N; Siekierzynska A; Southey MC; Myszka A
    Genet Res (Camb); 2020 Aug; 102():e6. PubMed ID: 32772980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRCA1 founder mutations do not contribute to increased risk of gastric cancer in the Polish population.
    Ławniczak M; Jakubowska A; Białek A; Lubiński J; Jaworska-Bieniek K; Kaczmarek K; Starzyńska T
    Hered Cancer Clin Pract; 2016; 14():3. PubMed ID: 26779294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Founder mutations in BRCA1/2 are not frequent in Canadian Ashkenazi Jewish men with prostate cancer.
    Hamel N; Kotar K; Foulkes WD
    BMC Med Genet; 2003 Aug; 4():7. PubMed ID: 12911837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent mutations of BRCA1 and BRCA2 in Poland: an update.
    Szwiec M; Jakubowska A; Górski B; Huzarski T; Tomiczek-Szwiec J; Gronwald J; Dębniak T; Byrski T; Kluźniak W; Wokołorczyk D; Birkenfeld B; Akbari MR; Narod SA; Lubiński J; Cybulski C
    Clin Genet; 2015 Mar; 87(3):288-92. PubMed ID: 24528374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Common BRCA1 and BRCA2 mutations in breast cancer families: a meta-analysis from systematic review.
    Wang F; Fang Q; Ge Z; Yu N; Xu S; Fan X
    Mol Biol Rep; 2012 Mar; 39(3):2109-18. PubMed ID: 21643751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ethnic aspects of hereditary breast cancer in the region of Siberia].
    Cherdyntseva NV; Pisareva LF; Ivanova AA; Panferova YV; Malinovskaya EA; Odintsova IN; Doroshenko AV; Gervas PA; Slonimskaya EM; Shivit-ool AA; Dvornichenko VV; Choinzonov YL
    Vestn Ross Akad Med Nauk; 2014; (11-12):72-9. PubMed ID: 25971130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Founder BRCA1 mutations and two novel germline BRCA2 mutations in breast and/or ovarian cancer families from North-Eastern Poland.
    van Der Looij M; Wysocka B; Brozek I; Jassem J; Limon J; Olah E
    Hum Mutat; 2000 May; 15(5):480-1. PubMed ID: 10790213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer.
    Górski B; Byrski T; Huzarski T; Jakubowska A; Menkiszak J; Gronwald J; Pluzańska A; Bebenek M; Fischer-Maliszewska L; Grzybowska E; Narod SA; Lubiński J
    Am J Hum Genet; 2000 Jun; 66(6):1963-8. PubMed ID: 10788334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selected Aspects of Molecular Diagnostics of Constitutional Alterations in BRCA1 and BRCA2 Genes Associated with Increased Risk of Breast Cancer in the Polish Population.
    Górski B
    Hered Cancer Clin Pract; 2006 Aug; 4(3):142-52. PubMed ID: 20223018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BRCA1 and BRCA2 mutation analysis in breast-ovarian cancer families from northeastern Poland.
    Perkowska M; BroZek I; Wysocka B; Haraldsson K; Sandberg T; Johansson U; Sellberg G; Borg A; Limon J
    Hum Mutat; 2003 May; 21(5):553-4. PubMed ID: 12673801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families.
    Levy-Lahad E; Catane R; Eisenberg S; Kaufman B; Hornreich G; Lishinsky E; Shohat M; Weber BL; Beller U; Lahad A; Halle D
    Am J Hum Genet; 1997 May; 60(5):1059-67. PubMed ID: 9150153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of germline BRCA1 mutations among breast cancer families in Northeastern Iran.
    Kooshyar MM; Nassiri M; Mahdavi M; Doosti M; Parizadeh A
    Asian Pac J Cancer Prev; 2013; 14(7):4339-45. PubMed ID: 23992000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel germline mutations and unclassified variants of BRCA1 and BRCA2 genes in Chinese women with familial breast/ovarian cancer.
    Cao WM; Gao Y; Yang HJ; Xie SN; Ding XW; Pan ZW; Ye WW; Wang XJ
    BMC Cancer; 2016 Feb; 16():64. PubMed ID: 26852015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.
    Satagopan JM; Boyd J; Kauff ND; Robson M; Scheuer L; Narod S; Offit K
    Clin Cancer Res; 2002 Dec; 8(12):3776-81. PubMed ID: 12473589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of BRCA1 and BRCA2 mutations in Pakistani breast and ovarian cancer patients.
    Rashid MU; Zaidi A; Torres D; Sultan F; Benner A; Naqvi B; Shakoori AR; Seidel-Renkert A; Farooq H; Narod S; Amin A; Hamann U
    Int J Cancer; 2006 Dec; 119(12):2832-9. PubMed ID: 16998791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in Hungary.
    Van Der Looij M; Szabo C; Besznyak I; Liszka G; Csokay B; Pulay T; Toth J; Devilee P; King MC; Olah E
    Int J Cancer; 2000 Jun; 86(5):737-40. PubMed ID: 10797299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRCA1 founder mutations and beyond in the Polish population: A single-institution BRCA1/2 next-generation sequencing study.
    Kowalik A; Siołek M; Kopczyński J; Krawiec K; Kalisz J; Zięba S; Kozak-Klonowska B; Wypiórkiewicz E; Furmańczyk J; Nowak-Ozimek E; Chłopek M; Macek P; Smok-Kalwat J; Góźdź S
    PLoS One; 2018; 13(7):e0201086. PubMed ID: 30040829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women.
    Abeliovich D; Kaduri L; Lerer I; Weinberg N; Amir G; Sagi M; Zlotogora J; Heching N; Peretz T
    Am J Hum Genet; 1997 Mar; 60(3):505-14. PubMed ID: 9042909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.